317 related articles for article (PubMed ID: 21257517)
1. Faecal egg count reduction test to detect lack of efficacy of triclabendazole.
Daniel R; van Dijk J; Williams D
Vet Rec; 2010 Nov; 167(19):759. PubMed ID: 21257517
[No Abstract] [Full Text] [Related]
2. Resistance of Fasciola hepatica to triclabendazole.
Overend DJ; Bowen FL
Aust Vet J; 1995 Jul; 72(7):275-6. PubMed ID: 8534235
[No Abstract] [Full Text] [Related]
3. Composite faecal egg count reduction test to detect resistance to triclabendazole in Fasciola hepatica.
Daniel R; van Dijk J; Jenkins T; Akca A; Mearns R; Williams DJ
Vet Rec; 2012 Aug; 171(6):153, 1-5. PubMed ID: 22791519
[TBL] [Abstract][Full Text] [Related]
4. Extension of the prepatent period of Fasciola hepatica in infected animals following treatment with triclabendazole.
Büscher G; Bowen FL; Strong MB; Allison JR; Richards RJ
Vet Rec; 1987 May; 120(19):460-1. PubMed ID: 3603988
[No Abstract] [Full Text] [Related]
5. A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole.
Fawcett AR
Vet Rec; 1990 Nov; 127(20):492-3. PubMed ID: 2275087
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of closantel and triclabendazole against Fasciola hepatica in experimentally infected sheep.
Maes L; Vanparijs O; Lauwers H; Deckers W
Vet Rec; 1990 Nov; 127(18):450-2. PubMed ID: 2275080
[TBL] [Abstract][Full Text] [Related]
7. Lack of reversion in triclabendazole-resistant Fasciola hepatica.
Borgsteede FH; Moll L; Vellema P; Gaasenbeek CP
Vet Rec; 2005 Mar; 156(11):350-1. PubMed ID: 15789649
[No Abstract] [Full Text] [Related]
8. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep.
Ortiz P; Scarcella S; Cerna C; Rosales C; Cabrera M; Guzmán M; Lamenza P; Solana H
Vet Parasitol; 2013 Jul; 195(1-2):118-21. PubMed ID: 23352107
[TBL] [Abstract][Full Text] [Related]
9. Field trials of triclabendazole against mixed age infections of Fasciola hepatica in sheep and cattle.
Stansfield DG; Lonsdale B; Lowndes PA; Reeves EW; Schofield DM
Vet Rec; 1987 May; 120(19):459-60. PubMed ID: 3603987
[No Abstract] [Full Text] [Related]
10. Efficacy of triclabendazole against Fasciola hepatica in sheep and goats.
Wolff K; Eckert J; Schneiter G; Lutz H
Vet Parasitol; 1983 Sep; 13(2):145-50. PubMed ID: 6685399
[TBL] [Abstract][Full Text] [Related]
11. Experimental infection of bighorn sheep with liver flukes (Fasciola hepatica).
Foreyt WJ
J Wildl Dis; 2009 Oct; 45(4):1217-20. PubMed ID: 19901401
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and economic consequences of triclabendazole resistance in Fasciola hepatica in a sheep flock in south-east Scotland.
Sargison ND; Scott PR
Vet Rec; 2011 Feb; 168(6):159. PubMed ID: 21493511
[TBL] [Abstract][Full Text] [Related]
13. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
[TBL] [Abstract][Full Text] [Related]
14. Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep.
Turner K; Armour J; Richards RJ
Vet Rec; 1984 Jan; 114(2):41-2. PubMed ID: 6719804
[No Abstract] [Full Text] [Related]
15. Lack of efficacy of triclabendazole against Fasciola hepatica is present on sheep farms in three regions of England, and Wales.
Kamaludeen J; Graham-Brown J; Stephens N; Miller J; Howell A; Beesley NJ; Hodgkinson J; Learmount J; Williams D
Vet Rec; 2019 Apr; 184(16):502. PubMed ID: 30824600
[TBL] [Abstract][Full Text] [Related]
16. A field trial with triclabendazole for the control of fascioliasis.
Owen IL
Aust Vet J; 1987 Feb; 64(2):59-61. PubMed ID: 3606508
[No Abstract] [Full Text] [Related]
17. Efficacy of an anthelmintic combination in sheep infected with Fasciola hepatica resistant to albendazole and clorsulon.
Martínez-Valladares M; Cordero-Pérez C; Rojo-Vázquez FA
Exp Parasitol; 2014 Jan; 136():59-62. PubMed ID: 24211419
[TBL] [Abstract][Full Text] [Related]
18. Comparative kinetics of serological and coproantigen ELISA and faecal egg count in cattle experimentally infected with Fasciola hepatica and following treatment with triclabendazole.
Brockwell YM; Spithill TW; Anderson GR; Grillo V; Sangster NC
Vet Parasitol; 2013 Sep; 196(3-4):417-26. PubMed ID: 23643623
[TBL] [Abstract][Full Text] [Related]
19. The field evaluation of albendazole and triclabendazole efficacy against Fasciola hepatica by coproantigen ELISA in naturally infected sheep.
Novobilský A; Averpil HB; Höglund J
Vet Parasitol; 2012 Nov; 190(1-2):272-6. PubMed ID: 22818198
[TBL] [Abstract][Full Text] [Related]
20. On farm evaluation of the coproantigen ELISA and coproantigen reduction test in Scottish sheep naturally infected with Fasciola hepatica.
Gordon DK; Zadoks RN; Stevenson H; Sargison ND; Skuce PJ
Vet Parasitol; 2012 Jul; 187(3-4):436-44. PubMed ID: 22421492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
